跳转至内容
Merck
CN

主要文件

查看所有文档

810158P

Avanti

16:0 Liss Rhod PE

Avanti Research™ - A Croda Brand

别名:

1,2-棕榈酰基-sn-甘油基-3-磷酸乙醇胺-N-(丽丝胺罗丹明 B 磺酰基) (铵盐)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C64H105N4O14PS2
化学文摘社编号:
384833-01-6
分子量:
1249.64
UNSPSC Code:
12352211
NACRES:
NA.25
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 1 mg (810158P-1mg), pkg of 5 × 1 mg (810158P-5mg), pkg of 5 × 2 mg (810158P-10mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@@](COP([O-])(OCCNS(=O)(C1=CC(S(=O)([O-])=O)=C(C2=C3C=CC(C=C3OC4=C2C=CC(N(CC)CC)=C4)=[N+](CC)CC)C=C1)=O)=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+]

InChI

1S/C64H102N3O14PS2.H3N/c1-7-13-15-17-19-21-23-25-27-29-31-33-35-37-62(68)77-50-54(80-63(69)38-36-34-32-30-28-26-24-22-20-18-16-14-8-2)51-79-82(70,71)78-46-45-65-83(72,73)55-41-44-58(61(49-55)84(74,75)76)64-56-42-39-52(66(9-3)10-4)47-59(56)81-60-48-53(40-4

InChI key

GGSIOFFNWNFZNH-KINGROEASA-N

Application

16：0 Liss Rhod PE或称1,2-二棕榈酰-sn-甘油-3-磷酸乙醇胺-N-（ 丽丝胺罗丹明B磺酰基）（铵盐）已被用于：
  • 体外脂质体管状结构检测（liposome tubulation assay）用大脑极性脂质混合物
  • 作为脂质体中的对照用于测定载PTX脂质体的稳定性
  • 形成脂质体以了解驱动蛋白运动蛋白（KIF5B）与磷脂酰肌醇4,5-二磷酸酯（PtdIns（4,5）P2）的结合，该结合导致自溶酶体管状结构的生成

16:0 Liss Rhod PE也可用于脂质体浮选试验以分析蛋白质-脂质相互作用并可用于形成单层小囊泡以确定脂质双层中的膜扩散。

Packaging

5 mL 棕色玻璃螺旋盖小瓶 (810158P-1 mg)
5 mL 棕色玻璃螺旋盖小瓶 (810158P-10 mg)
5 mL 棕色玻璃螺旋盖小瓶 (810158P-5 mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Still not finding the right product?

Explore all of our products under 16:0 Liss Rhod PE

存储类别

11 - Combustible Solids

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系 客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Fluorescent Lipid Probes - Avanti Research™

Explore full-spectrum fluorophores, fluorescent lipids, and probes for imaging, membrane studies, and labeling with TopFluor™, squaraines, and more.

Madi El-Haj et al.
Immunologic research, 67(4-5), 337-347 (2019-11-23)
The considerable variability of responses amongst subjects to disease triggers and immunotherapies is a major obstacle to designing better immune-based therapies. Therefore, development of patient-tailored precision medicine that improves the efficacy of immunomodulatory drugs is necessary. The individualized response to
Hamed Hamedinasab et al.
International journal of biological macromolecules (2019-11-27)
The purpose of the present investigation was to formulate NAC (N-acetylcysteine)-loaded chitosan (CH)-coated liposome aiming at obtaining an effective formulation able to ensure a prolonged and controlled release of NAC to the lung by inhalation. Empty liposomes [(DPPG/Chol/DPPG with different
Kazunori Takano et al.
The EMBO journal, 27(21), 2817-2828 (2008-10-17)
Extended Fer-CIP4 homology (EFC)/FCH-BAR (F-BAR) domains generate and bind to tubular membrane structures of defined diameters that are involved in the formation and fission of endocytotic vesicles. Formin-binding protein 17 (FBP17) and Toca-1 contain EFC/F-BAR domains and bind to neural
查看所有相关文献

全球贸易项目编号

货号GTIN
810158P-10MG04061835185511
810158P-1MG04061835185528
810158P-5MG04061835185535